In a first-of-its-kind procedure in the United States, Loyola University Medical Center physicians have deployed an aortic valve by going through a patient's abdomen.
[More]
MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation than two dimensional echocardiography, a new study indicates.
[More]
The Society of Thoracic Surgeons has released a set of clinical practice guidelines to address major advances in the evaluation and management of patients with aortic valve disease.
[More]
All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to results from the PARTNER study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
[More]
The new Sapien XT aortic valve showed a non-significantly lower rate of death and strokes at 30 days than the original model, and both valves demonstrated notably better short-term outcomes than seen with the Sapien system in PARTNER I, according to the first results from the PARTNER II study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
[More]
The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) have received a unique investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to study "alternative access" approaches for transcatheter aortic valve replacement (TAVR) using the STS/ACC TVT Registry.
[More]
People who carry a lipoprotein(a) gene variant are at increased risk for aortic valve calcification and aortic stenosis, suggest study findings.
[More]
Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis.
[More]
St. Jude Medical, Inc., a global medical device company, today announced the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial.
[More]
94-year old Santa Monica resident Vivian Valentine has much to be thankful for this Thanksgiving. A new life-saving heart valve procedure done without traditional open heart surgery has given her a new lease on life.
[More]
St. Jude Medical, Inc., a global medical device company, today announced it has received European CE Mark approval for its 23 mm Portico Transcatheter Aortic Heart Valve and Transfemoral Delivery System.
[More]
US study results indicate that cardiopulmonary exercise is well tolerated, even when performed by individuals with high-risk cardiovascular disease.
[More]
A study found that transcatheter aortic valve replacement (TAVR) yielded lower mortality rates after three years compared with medical therapy in patients deemed to be ineligible for conventional aortic valve surgery.
[More]
Unicuspid aortic valves may be reconstructed with tricuspidization using glutaraldehyde-treated autologous pericardium, with excellent early results and no mortality or major morbidity, the results of a preliminary study suggest.
[More]
Morton Plant Hospital is the first hospital in the Tampa Bay area to perform Transcatheter Aortic Valve Replacement (TAVR) by the transapical approach. Transapical TAVR is the latest FDA-approved treatment for people suffering from severe aortic stenosis.
[More]
Interventional cardiologists at UK HealthCare's Gill Heart Institute have successfully performed the facility's first two transcatheter aortic valve replacements.
[More]
Boston Scientific has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus Valve System in up to 120 patients with severe aortic valve disease.
[More]
CBH is the first hospital in Central Kentucky to perform the transcatheter aortic valve replacement (TAVR) procedure. Four patients with diseased aortic heart valves who were deemed too sick to withstand conventional open-heart surgery to replace their valves have undergone this new heart valve replacement procedure at Central Baptist Hospital.
[More]
Transcatheter aortic valve implantation (TAVI) leads to meaningful improvements in health-related quality of life in patients with severe aortic stenosis that are maintained for at least 1 year, according to a study presented at ESC Congress 2012.
[More]
Women with severe aortic stenosis are 40% less likely to die after transcatheter aortic valve implantation (TAVI) than men, reveals the latest data from the largest study to date of gender differences in outcomes after TAVI.
[More]